Oligohydramnios: Difference between revisions
No edit summary |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 20: | Line 20: | ||
The use of oligohydramnios as a predictor of gestational complications is controversial.<ref name="pmid17689653">{{cite journal |author=Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF |title=A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis |journal=Am. J. Obstet. Gynecol. |volume=197 |issue=2 |pages=207.e1–7; discussion 207.e7–8 |year=2007 |pmid=17689653 |doi=10.1016/j.ajog.2007.04.048}}</ref><ref name="pmid17896253">{{cite journal |author=Elsandabesee D, Majumdar S, Sinha S |title=Obstetricians' attitudes towards 'isolated' oligohydramnios at term |journal=Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology |volume=27 |issue=6 |pages=574–6 |year=2007 |pmid=17896253 |doi=10.1080/01443610701469669}}</ref> | The use of oligohydramnios as a predictor of gestational complications is controversial.<ref name="pmid17689653">{{cite journal |author=Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF |title=A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis |journal=Am. J. Obstet. Gynecol. |volume=197 |issue=2 |pages=207.e1–7; discussion 207.e7–8 |year=2007 |pmid=17689653 |doi=10.1016/j.ajog.2007.04.048}}</ref><ref name="pmid17896253">{{cite journal |author=Elsandabesee D, Majumdar S, Sinha S |title=Obstetricians' attitudes towards 'isolated' oligohydramnios at term |journal=Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology |volume=27 |issue=6 |pages=574–6 |year=2007 |pmid=17896253 |doi=10.1080/01443610701469669}}</ref> | ||
==Causes== | |||
===Drug Side Effect=== | |||
:*[[Ado-trastuzumab emtansine]] | |||
:*[[Pertuzumab]] | |||
==References== | ==References== | ||
| Line 33: | Line 38: | ||
[[Category:Obstetrics]] | [[Category:Obstetrics]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 14:21, 20 February 2015
| Oligohydramnios | |
| ICD-10 | O41.0 |
|---|---|
| ICD-9 | 658.0 |
| DiseasesDB | 9202 |
| MeSH | D016104 |
|
WikiDoc Resources for Oligohydramnios |
|
Articles |
|---|
|
Most recent articles on Oligohydramnios Most cited articles on Oligohydramnios |
|
Media |
|
Powerpoint slides on Oligohydramnios |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Oligohydramnios at Clinical Trials.gov Trial results on Oligohydramnios Clinical Trials on Oligohydramnios at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Oligohydramnios NICE Guidance on Oligohydramnios
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Oligohydramnios Discussion groups on Oligohydramnios Patient Handouts on Oligohydramnios Directions to Hospitals Treating Oligohydramnios Risk calculators and risk factors for Oligohydramnios
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Oligohydramnios |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oligohydramnios is a condition in pregnancy characterised by a deficiency in amniotic fluid.
The use of oligohydramnios as a predictor of gestational complications is controversial.[1][2]
Causes
Drug Side Effect
References
- ↑ Johnson JM, Chauhan SP, Ennen CS, Niederhauser A, Magann EF (2007). "A comparison of 3 criteria of oligohydramnios in identifying peripartum complications: a secondary analysis". Am. J. Obstet. Gynecol. 197 (2): 207.e1–7, discussion 207.e7–8. doi:10.1016/j.ajog.2007.04.048. PMID 17689653.
- ↑ Elsandabesee D, Majumdar S, Sinha S (2007). "Obstetricians' attitudes towards 'isolated' oligohydramnios at term". Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 27 (6): 574–6. doi:10.1080/01443610701469669. PMID 17896253.